GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 24.15
+0.89 (3.83%)
At close: Jul 31, 2026
GemPharmatech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 830.61 | 793.39 | 686.84 | 622.19 | 516.55 | 393.79 |
Revenue Growth | 18.56% | 15.51% | 10.39% | 20.45% | 31.17% | 50.35% |
Gross Profit Gross Profit Growth | 530.03 | 504.45 | 425.51 | 419.33 | 366.33 | 292.51 |
Operating Income Operating Income Growth | 171.12 | 152.28 | 91.83 | 111.42 | 98.39 | 96.4 |
Net Income Net Income Growth | 159.76 | 142.64 | 109.82 | 158.91 | 164.67 | 124.93 |
Earnings Per Share EPS Growth | 0.40 | 0.35 | 0.27 | 0.39 | 0.42 | 0.35 |
EPS Growth | 48.42% | 29.63% | -30.77% | -7.14% | 20.00% | 66.67% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Commercial Mouse Model Sales Commercial Mouse Model Sales Growth | 438.77 |
Functional Efficacy Business Functional Efficacy Business Growth | 200.19 |
Custom Breeding Business Custom Breeding Business Growth | 83.99 |
Model Creation Business Model Creation Business Growth | 47.48 |
Agent Import and Export and Others Agent Import and Export and Others Growth | 22.24 |
Unallocated Other Operations Unallocated Other Operations Growth | 0.72 |
Total Total Growth | 793.39 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,086 | 1,267 | 1,169 | 1,318 | 1,213 | 499.31 |
Total Debt Total Debt Growth | 259.51 | 291.31 | 132.48 | 121.62 | 17.86 | 25.2 |
Net Cash (Debt) Net Cash Growth | 826.11 | 976.06 | 1,036 | 1,196 | 1,195 | 474.11 |
Net Cash Growth | -15.15% | -5.81% | -13.39% | 0.11% | 152.07% | -8.68% |
Net Cash Per Share Net Cash Per Share Growth | 2.07 | 2.40 | 2.55 | 2.94 | 3.05 | 1.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 249.66 | 227.03 | 90.31 | 116.57 | 105.98 | 113.31 |
Capital Expenditures CapEx Growth | -88.28 | -104.99 | -113.68 | -205.9 | -190.31 | -89.07 |
Free Cash Flow Free Cash Flow Growth | 161.38 | 122.04 | -23.36 | -89.33 | -84.33 | 24.24 |
Free Cash Flow Growth | 2058.07% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.81% | 63.58% | 61.95% | 67.40% | 70.92% | 74.28% |
Operating Margin | 20.60% | 19.19% | 13.37% | 17.91% | 19.05% | 24.48% |
Pretax Margin | 22.61% | 20.79% | 17.36% | 25.92% | 33.62% | 36.39% |
Profit Margin | 19.23% | 17.98% | 15.99% | 25.54% | 31.88% | 31.72% |
FCF Margin | 19.43% | 15.38% | -3.40% | -14.36% | -16.33% | 6.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.220 | 0.220 | 0.140 | 0.160 | 0.041 |
Dividend Per Share Growth | 57.14% | 57.14% | -12.50% | 290.24% | - |
Dividend Yield | 0.91% | 1.45% | 1.11% | 0.82% | 0.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 60.25 | 44.15 | 47.80 | 51.99 | 59.88 | - |
Forward PE | 50.31 | 43.06 | 23.62 | 36.05 | 40.76 | - |
P/FCF Ratio | 61.20 | 51.60 | - | - | - | - |
PS Ratio | 11.89 | 7.94 | 7.64 | 13.28 | 19.09 | - |